Skip to content

QuidelOrtho Corporation QDEL Options canceled (in dollars per share)

Options canceled (in dollars per share) at other companies

Ondas, Inc.
 logo
Ondas, Inc. ONDS
$5.42+274%
Xylem logo
XylemXYL
$127.87+13.3%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$15.04
Avanos Medical logo
Avanos MedicalAVNS
$31.83-14.8%
Playtika Holding Corp. logo
Playtika Holding Corp.PLTK
$16.65-12.0%
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
$0.00

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.

The official record: QuidelOrtho Corporation’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's options canceled (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's options canceled (in dollars per share)?
QuidelOrtho Corporation (QDEL) reported options canceled (in dollars per share) of $96.45 in Q4 2025.
What does options canceled (in dollars per share) mean?
The weighted-average exercise price of stock options that were cancelled or forfeited during the period. This metric reflects the value threshold of equity incentives that failed to vest, providing context on the company's historical compensation strategy.